If so this would be predicted to pertain as the predominant mode of IRF4 occupancy in EBV-driven B-cell malignancies, such as EBV-associated DLBCL and EBV-associated classical Hodgkin lymphoma. Here, IRF4 is linked to Hodgkins lymphoma.